Have a personal or library account? Click to login
Serial Magnetic Resonance Imaging Follow-up of a Chihuahua with Meningoencephalitis of Unknown Origin Treated with Prednisolone and Imatinib: A Case Report Cover

Serial Magnetic Resonance Imaging Follow-up of a Chihuahua with Meningoencephalitis of Unknown Origin Treated with Prednisolone and Imatinib: A Case Report

By: Woo Dae Park  
Open Access
|Dec 2025

References

  1. Talarico LR, Schatzberg SJ: Idiopathic granulomatous and necrotizing inflammatory CNS disease of dogs: a review and future perspectives. J Vet Intern Med 2010, 24:1189-1197.
  2. Cornelis I, Van Ham L, Gielen I, De Decker S, Bhatti SFM: Clinical presentation, diagnostic findings, prognostic factors, treatment and outcome in dogs with meningoencephalomyelitis of unknown origin: A review. Vet J 2019, 244:37-44.
  3. Lowrie M, Smith PM, Garosi L: Meningoencephalitis of unknown origin: investigation of prognostic factors and outcome using a standard treatment protocol. Vet Rec 2013, 172(20):527.
  4. Song JH, Yu DH, Lee HC, Hwang TS, Kim YJ, An SJ, Jung DI: Evaluation of treatment with a combination of mycophenolate mofetil and prednisolone in dogs with meningoencephalomyelitis of unknown etiology: a retrospective study of 86 cases (2009–2017). BMC Vet Res 2020, 16(1):192.
  5. Brady SL, Woodward AP, le Chevoir M: Survival time and relapse in dogs with meningoencephalomyelitis of unknown origin treated with prednisolone and ciclosporin: a retrospective study. Aust Vet J 2020, 98(10):491-498.
  6. Song KH, Lee JE, Kang BT: Long-term management of canine disseminated granulomatous meningoencephalitis with imatinib mesylate: a case report. J Biomed Transl Res 2018, 19(3):137–142.
  7. Song JH, Jung DI: Use of imatinib mesylate in a dog with meningoencephalitis of unknown etiology. J Biomed Transl Res 2020, 21(3):137-142.
  8. Gonçalves R, De Decker S, Walmsley G, Maddox TW: Magnetic resonance imaging prognostic factors for survival and relapse in dogs with meningoencephalitis of unknown origin. Front Vet Sci 2024, 11:1370882.
  9. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S, Sawyers CL: Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001, 344:1031–1037.
  10. Soulé C, Blond L, Cavalerie R, Piazza S, Baudin-Tréhiou C: Evolution of brain magnetic resonance imaging lesions in dogs treated for meningoencephalomyelitis of unknown origin between initial diagnosis and relapse. J Vet Intern Med 2025, 39(3):e70086.
  11. Gonçalves R, Walmsley G, Maddox TW: Brain atrophy in dogs with meningoencephalitis of unknown origin. J Vet Intern Med 2025, 39:e70095.
  12. Heidemann PL, Erhald B, Koch BC, Gredal H, Berendt M, Matiasek K, Rupp S, Tipold A, Stein VM, Rosati M, Wessmann A, Pakozdy A, Ruel Y, Bhatti SFM: Investigation of side effects to treatment and cause of death in 63 Scandinavian dogs suffering from meningoencephalitis of unknown origin: a retrospective study. Acta Vet Scand 2023, 65(1):46.
DOI: https://doi.org/10.2478/acve-2025-0040 | Journal eISSN: 1820-7448 | Journal ISSN: 0567-8315
Language: English
Page range: 521 - 533
Submitted on: Sep 17, 2025
|
Accepted on: Nov 13, 2025
|
Published on: Dec 11, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2025 Woo Dae Park, published by University of Belgrade, Faculty of Veterinary Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.